Bank of Hawaii’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,346
Closed -$566K 244
2025
Q1
$566K Sell
3,346
-1,246
-27% -$205K 0.03% 163
2024
Q4
$693K Sell
4,592
-53
-1% -$8.24K 0.04% 151
2024
Q3
$721K Sell
4,645
-17
-0.4% -$2.54K 0.03% 161
2024
Q2
$638K Sell
4,662
-585
-11% -$80.1K 0.03% 168
2024
Q1
$698K Sell
5,247
-659
-11% -$85.5K 0.03% 165
2023
Q4
$814K Sell
5,906
-83
-1% -$10.9K 0.04% 147
2023
Q3
$730K Sell
5,989
-329
-5% -$43.8K 0.04% 153
2023
Q2
$888K Sell
6,318
-163
-3% -$22.5K 0.05% 146
2023
Q1
$917K Buy
6,481
+597
+10% +$85.4K 0.05% 143
2022
Q4
$920K Buy
5,884
+234
+4% +$33.6K 0.06% 132
2022
Q3
$693K Sell
5,650
-32
-0.6% -$4.21K 0.05% 145
2022
Q2
$756K Buy
5,682
+39
+0.7% +$5.31K 0.05% 149
2022
Q1
$772K Sell
5,643
-151
-3% -$21K 0.04% 156
2021
Q4
$1M Buy
5,794
+11
+0.2% +$1.67K 0.05% 142
2021
Q3
$840K Sell
5,783
-71
-1% -$10.4K 0.05% 158
2021
Q2
$773K Sell
5,854
-226
-4% -$29.6K 0.04% 172
2021
Q1
$780K Sell
6,080
-14
-0.2% -$1.73K 0.05% 170
2020
Q4
$726K Buy
6,094
+138
+2% +$16.8K 0.05% 174
2020
Q3
$682K Buy
5,956
+1,680
+39% +$198K 0.05% 162
2020
Q2
$487K Buy
+4,276
New +$454K 0.04% 198

Other funds holding DGX

Bank of Hawaii's DGX Position: Q2 2025 in Review

Bank of Hawaii sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 3,346 shares — an estimated $566K sold.

Bank of Hawaii first reported a position in DGX in Q2 2020 and held it in 20 quarters. The position peaked at $1M in Q4 2021. 991 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Bank of Hawaii reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Bank of Hawaii sold 3,346 Quest Diagnostics shares in Q2 2025, an estimated $566K.
  • Bank of Hawaii first reported a position in Quest Diagnostics in Q2 2020 and held it in 20 quarters.
  • Bank of Hawaii's Quest Diagnostics position peaked at $1M in Q4 2021.
  • 991 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Bank of Hawaii's 13F filing for Q2 2025, filed 14 Aug 2025.